1 Product identity
Ingredient risk
1 ingredient to use with caution

Chewable C 500 mg

BrandAvPAKSingle Vitamin and Mineral Tablet or Pill 14 ingredients 1 caution DSLD #271321
Net contents: 50 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2022-07-21
2 Ingredients (14)
IngredientGroupSafety
Vitamin CVitamin C (unspecified)
SodiumSodiumConditionally Safe
SucroseSucrose
SorbitolSorbitol
CelluloseCellulose
Silicon DioxideSiliconGenerally Safe
Stearic AcidStearic Acid
Artificial colorColor
FructoseFructose
Hydroxypropyl MethylcelluloseHypromellose
Magnesium StearateMagnesiumUse with Caution
natural Orange flavorOrange (unspecified)
StarchStarch
SucraloseSucraloseConditionally Safe
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Vitamin C — Limited Evidence
⚠ GI distress at high doses
⚠ Kidney stones risk >1g/day
Sodium — Conditionally Safe
⚠ Hypertension
⚠ Fluid retention
Silicon — Generally Safe
⚠ Very low toxicity
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Sucralose — Conditionally Safe
⚠ May affect gut microbiome
⚠ Heating may produce chlorinated compounds
4 Label claims
• Nutrient
• All Other
• Structure/Function
5 Data source
DSLD ID271321
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2022-07-21
6 More from AvPAK
View AvPAK Safety Scorecard → 14 products
A 3000 mcgCalcium 600+D3Calcium Citrate Maximum +D3Folic Acid 800 mcgFolic Acid 800 mcgMaximum Strength Glucosamine Chondroitin
7 Cite this page
Vancouver
Pkhakadze G. Chewable C 500 mg — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jun 24]. Available from: https://supplement.ge/products/chewable-c-500-mg-271321/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG